Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Soria F, D’Andrea D, Moschini M, Giordano A, Mazzoli S, Pizzuto G et al (2020) Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder Is there a possibility to avoid it in well-selected patients? Urol Oncol Semin Orig Investig 38(3):77.e1-77.e7
2. Mariappan P, Zachou A, Grigor KM (2010) Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol 57(5):843–849
3. Divrik RT, Sahin AF, Yildirim U, Altok M, Zorlu F (2010) Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur Urol 58(2):185–190
4. Mori K, Miura N, Babjuk M, Karakiewicz PI, Mostafaei H, Laukhtina E, et al (2020) Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: A systematic review. Urol Oncol Semin Original Investig 38(10):774–782
5. Gregg JR, McCormick B, Wang L, Cohen P, Sun D, Penson DF et al (2016) Short term complications from transurethral resection of bladder tumor. Can J Urol Avr 23(2):8198–8203
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献